Cardiovascular comorbidity and its impact on patients with COVID-19
Top Cited Papers
Open Access
- 27 April 2020
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 55 (6), 2001227
- https://doi.org/10.1183/13993003.01227-2020
Abstract
Comorbid hypertension correlates with poorer outcomes in patients with Covid-19.Funding Information
- National Health Commission (NA)
- Guangdong Science and Technology Department (NA)
This publication has 8 references indexed in Scilit:
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysisEuropean Respiratory Journal, 2020
- Strategies for the prevention and management of coronavirus disease 2019European Respiratory Journal, 2020
- Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi ArabiaEmerging Infectious Diseases, 2020
- Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective studyEpidemiology and Infection, 2018
- Cultural factors influencing e-commerce usability in Saudi ArabiaInternational Journal of ADVANCED AND APPLIED SCIENCES, 2018
- Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2016
- Association of Age and Comorbidity on 2009 Influenza A Pandemic H1N1-Related Intensive Care Unit Stay in MassachusettsAmerican Journal of Public Health, 2014
- Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto AreaJAMA, 2003